On 6 December 2017
Claris Lifesciences will hold a meeting of the Board of Directors of the Company on 6 December 2017, to consider the letter received from Athanas Enterprise Private Limited for the proposal for voluntary delisting of the equity shares of the CompanyPowered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)